Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single‐Photon Emission Computed Tomography Study-Reference-Cited by-同舟云学术

Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single‐Photon Emission Computed Tomography Study

Published:2020-03-10 Issue:6 Volume:35 Page:1028-1036
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Palermo Giovanni¹,Giannoni Sara¹,Frosini Daniela¹,Morganti Riccardo²,Volterrani Duccio³,Bonuccelli Ubaldo¹,Pavese Nicola⁴⁵^ORCID,Ceravolo Roberto¹^ORCID

Affiliation:

1. Unit of Neurology, Department of Clinical and Experimental MedicineUniversity of Pisa Pisa Italy

2. Section of Statistics, University of Pisa Pisa Italy

3. Regional Center of Nuclear Medicine, Department of Clinical and Experimental MedicineUniversity of Pisa Pisa Italy

4. Clinical Ageing Research Unit, Translational and Clinical Research Institute, Newcastle University Newcastle upon Tyne United Kingdom

5. Department of Clinical Medicine, Nuclear Medicine and PETAarhus University Aarhus Denmark

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28008

Reference52 articles.

1. Neuropathology of Parkinson disease

2. Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease

3. Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias

4. The role of DAT-SPECT in movement disorders

5. Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐ to Mid‐Stage Parkinson's Disease Modification Trials;Movement Disorders Clinical Practice;2024-08-22

2. Sleep disorders cause Parkinson's disease or the reverse is true: Good GABA good night;CNS Neuroscience & Therapeutics;2024-03

3. Exploring the Distinct Effect of Age at Onset and Caudate Denervation on Cognitive Deficits in Early Parkinson’s Disease;aging and disease;2024

4. A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson’s disease: beneficial or detrimental effects;Inflammopharmacology;2023-03-24

5. Ginsenosides can target brain-derived neurotrophic factor to improve Parkinson's disease;Food & Function;2023